PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 32 filers reported holding PROFOUND MED CORP in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,924 | -21.6% | 1,071 | 0.0% | 0.00% | – |
| Q2 2023 | $13,933 | +114.3% | 1,071 | +53.0% | 0.00% | – |
| Q1 2023 | $6,503 | -7.1% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $7,000 | +133.3% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -12.5% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -20.0% | 700 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | +233.3% | 700 | +250.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -75.0% | 200 | -79.2% | 0.00% | – |
| Q2 2020 | $16,000 | +77.8% | 960 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | – | 960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 196,924 | $3,474,000 | 8.11% |
| Gagnon Advisors, LLC | 277,252 | $4,891,000 | 3.00% |
| GAGNON SECURITIES LLC | 779,533 | $13,751,000 | 2.93% |
| Taylor Wealth Management Partners | 166,364 | $2,935,000 | 1.34% |
| AWM Investment Company, Inc. | 348,939 | $6,155,000 | 1.01% |
| PCJ Investment Counsel Ltd. | 121,560 | $2,137,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $13,769,000 | 0.71% |
| Parkman Healthcare Partners LLC | 70,000 | $1,235,000 | 0.33% |
| Park West Asset Management LLC | 450,000 | $7,938,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $12,260,000 | 0.30% |